Literature DB >> 5076802

The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.

M B Garvey, J M Black.   

Abstract

A rapid slide test for the detection of degradation products of fibrinogen/fibrin (FDP) using a new antibody-coated latex particle is described. The latex particle has been specifically coated with antibody to fragments D and E. The latex agglutination test (Thrombo-Wellcotest) has been compared with the tanned red cell haemagglutination inhibition immunoassay (TRCHII) in 143 patients with a variety of clinical conditions. There is a high degree of agreement between the methods with a coefficient of correlation of 0.83. The method provides a rapid, simple screening test for fibrin degradation products.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5076802      PMCID： PMC477476          DOI： 10.1136/jcp.25.8.680

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  15 in total

1.  [The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities].

Authors:  V NUSSENZWEIG; M SELIGMANN; P GRABAR
Journal:  Ann Inst Pasteur (Paris)       Date:  1961-04

2.  Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.

Authors:  S Fisher; A P Fletcher; N Alkjaersig; S Sherry
Journal:  J Lab Clin Med       Date:  1967-12

3.  A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.

Authors:  D P Thomas; S Niewiarowski; A R Myers; K J Bloch; R W Colman
Journal:  N Engl J Med       Date:  1970-09-24       Impact factor: 91.245

4.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.

Authors:  J Hawiger; S Niewiarowski; V Gurewich; D P Thomas
Journal:  J Lab Clin Med       Date:  1970-01

5.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

6.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

7.  Latex-bound antifibrinogen test for plasma fibrinogen assay.

Authors:  D J Castelan; J Hirsh; M Martin
Journal:  J Clin Pathol       Date:  1968-09       Impact factor: 3.411

8.  Measurement of fibrinogen degradation products.

Authors:  R J Cohen
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

9.  Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.

Authors:  V J Marder; M O Matchett; S Sherry
Journal:  Am J Med       Date:  1971-07       Impact factor: 4.965

10.  Staphylococcal clumping with soluble fibrin mmonomer complexes.

Authors:  B Lipiński; J Hawiger; J Jeljaszewicz
Journal:  J Exp Med       Date:  1967-11-01       Impact factor: 14.307
View more
  11 in total

1.  Enhanced antiplasmin activity in acute renal failure.

Authors:  A Kanfer; A Vandewalle; M Beaufils; F Delarue; J D Sraer
Journal:  Br Med J       Date:  1975-10-25

2.  The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

Authors:  G Richardson
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

3.  Laboratory investigations of the DIC syndrome.

Authors:  I J Temperley; E Cullen
Journal:  Ir J Med Sci       Date:  1973-05       Impact factor: 1.568

4.  Prevention of pulmonary embolism.

Authors:  D R Jones; I M Macintyre; C V Ruckley
Journal:  Br Med J       Date:  1973-07-14

5.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

Authors:  R W Colman; A Bagdasarian; R C Talamo; C F Scott; M Seavey; J A Guimaraes; J V Pierce; A P Kaplan
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  The coagulopathy associated with aortic aneurysms.

Authors:  E P Gétaz; J H Louw
Journal:  Postgrad Med J       Date:  1977-11       Impact factor: 2.401

7.  Fibrinolysis-coagulation system in patients with cancer of the head and neck. Preliminary report.

Authors:  T Kosugi; I Takagi; Y Ariga; S Okada; T Morimitsu; H Mihara
Journal:  Arch Otorhinolaryngol       Date:  1982

8.  Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.

Authors:  N Toki; H Sumi; K Sasaki; I Boreisha; K C Robbins
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

9.  Disseminated intravascular coagulation in the pathogenesis of adult respiratory distress syndrome: 1. Clinical study.

Authors:  R Ogawa; T Kimura; T Fujita
Journal:  Jpn J Surg       Date:  1977-12

10.  Altered coagulation protein content after albumin resuscitation.

Authors:  C E Lucas; A M Ledgerwood; E F Mammen
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.